InMed Pharmaceuticals (INM) Net Income towards Common Stockholders (2019 - 2026)
InMed Pharmaceuticals (INM) reported Net Income towards Common Stockholders of -$2.33 million for fiscal Q1 2027 (quarter ended Sep 30, 2026), compared with -$1.73 million a year earlier.
Powered by 
Analysis
InMed Pharmaceuticals (INM) Net Income towards Common Stockholders (2019 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, InMed Pharmaceuticals' Net Income towards Common Stockholders came in at -$13.2 million; for FY2026 (ended Jun 30, 2026), it was -$12.99 million.
- By fiscal year, Net Income towards Common Stockholders came in at -$8.16 million in FY2025, -$7.7 million in FY2024, -$7.95 million in FY2023 and -$18.6 million in FY2022.
- Five-year quarterly Net Income towards Common Stockholders spans a low of -$7.87 million in fiscal Q4 2022 and a high of $4.7 million in fiscal Q4 2025.
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at -$5.88 million (Q4 2026), -$2.97 million (Q3 2026) and -$2.03 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 239.54 Bn | 223.24 Bn | 4.44 Bn | 1.69 Bn |
| 2 | Corning | 96.61 Bn | 88.91 Bn | 1.81 Bn | 680.00 Mn |
| 3 | Sherwin Williams | 85.84 Bn | 84.86 Bn | 3.28 Bn | 821.00 Mn |
| 4 | Air Products & Chemicals | 69.53 Bn | 72.40 Bn | - | - |
| 5 | LyondellBasell Industries | 39.13 Bn | 27.31 Bn | 1.50 Bn | 756.00 Mn |
| 6 | Nutrien | 34.78 Bn | 31.35 Bn | 1.86 Bn | 288.00 Mn |
| 7 | Ppg Industries | 27.48 Bn | 20.55 Bn | 1.76 Bn | 451.00 Mn |
| 8 | Qnity Electronics | 25.83 Bn | 22.27 Bn | 743.00 Mn | 183.00 Mn |
| 9 | Ati | 24.82 Bn | 22.90 Bn | 380.20 Mn | 189.80 Mn |
| 10 | InMed Pharmaceuticals | 8.79 Mn | 7.69 Mn | - | -2.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -2.33 Mn |
| Jun 30, 2026 | -5.88 Mn |
| Mar 31, 2026 | -2.97 Mn |
| Dec 31, 2025 | -2.03 Mn |
| Sep 30, 2025 | -1.73 Mn |
| Jun 30, 2025 | 4.70 Mn |
| Mar 31, 2025 | -2.12 Mn |
| Dec 31, 2024 | -2.58 Mn |
| Sep 30, 2024 | -1.68 Mn |
| Jun 30, 2024 | -1.96 Mn |
| Mar 31, 2024 | -1.72 Mn |
| Dec 31, 2023 | -1.48 Mn |
| Sep 30, 2023 | -2.54 Mn |
| Jun 30, 2023 | -338,391.00 |
| Mar 31, 2023 | -2.00 Mn |
| Dec 31, 2022 | -2.10 Mn |
| Sep 30, 2022 | -3.51 Mn |
| Jun 30, 2022 | -7.87 Mn |
| Mar 31, 2022 | -3.48 Mn |
| Dec 31, 2021 | -4.28 Mn |
API Access
InMed Pharmaceuticals Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=INM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "INM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=INM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();